New hope for rare genetic condition

Publicly released:
Australia; International; VIC
Credit: Tom van  Hattem, www.lab76.org
Credit: Tom van Hattem, www.lab76.org

WEHI researchers have discovered an important role of an enzyme called Microrchidia CW-type zinc finger 2 (MORC2), which modifies the structure of DNA for gene expression. Mutations in MORC2 can lead to Charcot-Marie-Tooth disease, a severe genetic condition that causes progressive muscle weakness and loss of sensation. Understanding how MORC2 functions opens the door to developing new therapies. By targeting its activity, researchers may be able to design drugs that restore its function and slow or stop disease progression.

Journal/
conference:
Nature Communications
Research:Paper
Organisation/s: WEHI, The University of Melbourne, Monash University
Funder: Charcot-Marie-Tooth Australia Research Grant, NHMRC Investigator Grant, NHMRC Ideas Grant , FSHD Society Fellowship, Chan Zuckerberg Initiative Grant
Media Contact/s
Contact details are only visible to registered journalists.